Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |